AlphaGrep UK
PRAX icon

AlphaGrep UK’s Praxis Precision Medicines PRAX Stock Holding History

AlphaGrep UK’s Portfolio PRAX Stock Details PRAX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$516K Buy
+1,772
New +$586K 0.15% 227
2026
Q2 		– Sell
-1,134
Closed -$365K – 907
2026
Q1 		$365K Buy
+1,134
New +$351K 0.11% 417

Other funds holding PRAX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
BlackRock
BlackRock New York $6.79T AUM 37.06% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.21T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.76T AUM
State Street
State Street Boston, Massachusetts $3.44T AUM 36.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.96T AUM 27.49% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.27T AUM 50.62% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $474B AUM 32.39% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 42.55% 1-Year Est. Return

AlphaGrep UK's PRAX Position: Q3 2026 in Review

AlphaGrep UK opened a new position in Praxis Precision Medicines (PRAX) in Q3 2026: 1,772 shares worth $516K. The stake represents 0.15% of the portfolio and ranks #227 among its holdings. This is a return to the name: AlphaGrep UK previously reported a position in PRAX as recently as Q1 2026.

AlphaGrep UK first reported a position in PRAX in Q1 2026 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold PRAX as of Q3 2026.

  • AlphaGrep UK held 1,772 shares of Praxis Precision Medicines worth $516K as of Q3 2026.
  • Praxis Precision Medicines was a new AlphaGrep UK position in Q3 2026.
  • Praxis Precision Medicines made up 0.15% of AlphaGrep UK's portfolio in Q3 2026, its #227 holding.
  • AlphaGrep UK first reported a position in Praxis Precision Medicines in Q1 2026 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Praxis Precision Medicines as of Q3 2026.

Based on AlphaGrep UK's 13F filing for Q3 2026, filed 12 Nov 2026.